Instituto D'Or de Pesquisa e Ensino SP

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Ovarian cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 31 trial

Status

• Active, not recruiting2 trials

Lead sponsor

• Gilead Sciences1 trial
• Latin American Cooperative Oncology Group1 trial

Running trials

• Active, not recruiting

  A Collaborative Trial of Niraparib to Evaluate Patients With Ovarian Cancer in the Expanded Access Program in Latin America

  NCT05857397· Latin American Cooperative Oncology Group· Source

• Recruiting

  Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

  NCT05633654· Phase 3· Gilead Sciences· Source